In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Blood Glucose Monitoring Devices Market Report
The global blood glucose monitoring devices market by revenue is expected to grow at a CAGR of 12% during the period 2021–2026.
The diabetes monitoring industry is growing at a steady rate because of the increasing prevalence of diabetes and the rise in chronic diseases. Globally, the incidence of diabetes has been increasing at an alarming rate due to changing lifestyles, growing alcohol consumption, and an increasing number of smokers. In emerging markets and newly industrializing countries, the number of new diabetes cases is expected to grow in the coming years significantly. Therefore, monitoring of blood glucose levels has proven to be essential for the management of the disease. The increasing awareness of diabetes is likely to increase the blood glucose monitoring devices market demand.
The following factors are likely to contribute to the growth of the blood glucose monitoring devices market during the forecast period:
• Increase in Diabetic Population
• Increased Demand for Self-Monitoring Devices due to Covid-19 Pandemic
• Emergence of Non-invasive Blood Glucose Monitoring Devices
The study considers the present scenario of the blood glucose monitoring devices market and its market dynamics for the period 2020?2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.
Global Blood Glucose Monitoring Devices Market Segmentation The global blood glucose monitoring devices market research report includes a detailed segmentation by product, end-users, usage, distribution channels, geography. The conventional blood glucose monitoring devices market accounted for a share of over 78%. One of the major factors contributing to conventional blood glucose monitoring devices’ growth is the increasing diabetic population globally, which is expected to reach over 578 million by 2030. The rise in obesity and the increase in the aging population in developed countries are other major factors that are obliquely influencing blood glucose monitoring devices market growth. Test strips, lancets and lancing devices, and meters & software are the major components that have been covered under the conventional blood glucose monitoring devices market.
A high prevalence of diabetes and changes in lifestyles have increased the usage of personal glucose monitoring devices. The need to monitor blood sugar levels is increasing the usage of these devices. Advances in technology have been playing an important role in the proliferation of BGM devices. The introduction of wireless glucose monitoring systems, which can be operated on a smartphone using Wi-Fi protocols, helps patients remotely monitor their sugar levels. In developed countries such as the UK, Spain, Germany, Italy, and the UK, self-monitoring glucose meter and CGM devices are completely reimbursed, making these devices cost-efficient, thereby driving patient usage.
The online channel is growing significantly in developing countries such as India and China. The increased competition among online vendors has affected the device cost, with high discounts driving consumers to opt for online stores. With the increasing smartphone usage in developing countries, the online distribution channel is likely to emerge as an important distribution channel. Hence, the high preference for online channels is likely to augur well for medical devices’ growth, especially blood glucometers.
The individual segment accounted for the largest glucose monitoring devices market share due to the wide acceptance of self-monitoring devices worldwide. These devices are majorly covered by insurance companies in several developed and developing countries. Morbidity and mortality from diabetes are extremely high in underdeveloped countries due to poor adherence to global diabetic guidelines. Therefore, the scope of self-testing is likely to increase among diabetic patients. Furthermore, the introduction of advanced devices with remote monitoring features has encouraged patients to use personal blood glucose monitoring devices.
By Product
• Conventional Blood glucose monitoring (BGM) Devices
o Blood Glucose Meters & Software
o Test Strips
o Lancing Devices & Lancets
• Continuous Glucose Monitoring (CGM) Devices
o Disposable Sensors
o Reusable Hardware
By Usage
• Personal BGM Devices
• Professional BGM Devices
By End-user
• Hospitals
• Individuals
• Others
By Distribution Channel
• Offline Stores
• Online Stores
INSIGHTS BY GEOGRAPHY North America dominated the blood glucose monitoring devices market due to its developed healthcare infrastructure and increased awareness of glucose monitors among patients. The usage of continuous glucose monitoring systems and self-monitoring blood glucose systems is high in the region. The US and Canada account for the majority of the blood glucose monitoring devices market share. The adoption of these devices is extremely high in the US. The usage of these devices has increased in the region as they are covered under medical reimbursement schemes. Hence, the demand for BGM devices is growing because of easy access to diabetic care, medical reimbursement coverage, and high affordability. Besides, the usage of BGM devices has increased with the outbreak of the COVID-19 pandemic as the virus is highly contiguous and increases the susceptibility of diabetic patients. Hence, the outbreak has increased the scope of self-monitoring BGM devices.
By Geography
• North America
o US
o Canada
• Europe
o UK
o Germany
o France
o Italy
o Spain
• APAC
o China
o Japan
o South Korea
o Australia
o India
• Latin America
o Brazil
o Mexico
o Argentina
o Columbia
• Middle East & Africa
o Saudi Arabia
o South Africa
o Turkey
o Iran
INSIGHTS BY VENDORS The global glucose monitoring devices market share is intensely competitive, subject to rapid technological changes, and is significantly affected by new product launches and other market activities. Medtronic’s Diabetes Group, F. Hoffmann-La Roche’s Diabetes Care, LifeScan, Abbott’s Diabetes Care Division, DEXCOM, and Ascensia Diabetes Care are the major global players operating in the blood glucose monitoring system market. Currently, these companies collectively account for significant shares. Several companies are developing or commercializing products for continuous and self-monitoring blood glucose devices in the market. The Medtronic Diabetes Group promotes a standalone sugar monitoring product, Guardian Connect, which has launched both internationally and in the US after receiving FDA approvals.
Other Prominent Vendors
• 77 Elektronika Kft
• Menarini Diagnostics
• ARKRAY
• ApexBio
• ACON
• AgaMatrix
• Alliance International
• Andon Health
• Braun Melsungen
• Bionime
• Beurer
• Bioptik
• EASYMAX
• ForaCare
• Hannox International
• Integrity Applications
• i-SENS
• MED TRUST
• Nova Biomedical
• Nemaura
• OK Biotech
• OSANG Healthcare
• Sanofi
• Terumo
• Trividia Health
• Rossmax International
• Ypsomed
KEY QUESTIONS ANSWERED 1. What is the estimated forecast of global blood glucose monitoring devices market size in 2026?
2. What is the opportunity for non-invasive blood glucose monitor market?
3. What is the growth projection of continuous blood glucose monitoring devices market share?
4. Who are the top players in the blood sugar monitoring market?
5. What is the market share of self-monitoring of blood glucose (SMBG)?
Our reports have been used by over 10K customers, including:
The global in-vitro diagnostics market size is projected to reach USD 96.0 billion by 2025 from USD 84.5 billion in 2020, at a CAGR of 2.6% during the forecast period. Market growth is attributed to the rising per capita income in developed and developing countries and technological advancements introduced in the in-vitro diagnostic devices. By...
The United States In Vitro Diagnostics (IVD) market is predicted to reach nearly US$ 37 Billion by 2026. In-vitro Diagnostics (IVD) serves a key role in the healthcare value chain by significantly influencing the quality of health outcomes, patient treatment, care and downstream resource requirements. With an aging population, technological...
Executive Summary Global In Vitro Diagnostics Market was valued at USD 61700.22 Million in the year 2018. As size of old age population is increasing globally, quality healthcare is required. Diagnostics have major role, as majority of clinical decisions are based on diagnostic test result. They assist in providing personalised...
The India household insecticides market is accounted to US$ 1,147.5 Mn in 2018 and is expected to grow at a CAGR of 5.4% during the forecast period 2019 - 2027, to account for US$ 1,829.6 Mn by 2027. The household insecticides market has been witnessing a remarkable growth in India from the last few years. Household insecticide products are...
United States In Vitro Diagnostics (IVD) market is expected to reach US$ 33.7 Billion by 2025. United States represents the largest IVD market across the world. With an aging population, technological advances and advent of point of care diagnostics, United States IVD market is slated to show substantial growth in the future. The increase...
With a population of more than 1 billion, China is the world’s largest country and therefore also its single largest potential market for goods and services. In the past ten years, China has led all major world economies in the average rate of growth in real GDP, total health expenditures, and government health expenditures. As an in vitro...
India as an IVD market opportunity is defined by its standing next to other populous countries with demonstrated economic promise for over the past decade - Brazil, Russia and China. IVD in India places India and its in vitro diagnostics (IVD) market in context, presenting current analysis of the Indian IVD industry and providing forecasts...
In vitro diagnostics testing is an indispensable tool in the modern medical practice. IVD tests are conducted with the help of various medical devices for the diagnosis of a number of diseases. With evolution in biotechnology, there has been a drastic change in the type of tests conducted for diagnosing various diseases, thus helping physicians...
In Mexico, there is a growing demand for new technologies in the laboratory sector and, as government and private hospital budgets increase, the market is expected to see an increase in demand for high-tech equipment and consumables. Mexico IVD Market Analysis focuses on the in vitro diagnostic (IVD) discipline including revenue data on the...
Scope of the Report The report entitled “Global In-Vitro Diagnostic (IVD) Market: Size, Trends & Forecasts (2017-2021)”, provides analysis of the global In-Vitro Diagnostic, with detailed analysis of market size and growth, and segmentation of the industry. The analysis includes the market by value, by products, by technology and...
In Vitro Diagnostics
World
Health Expenditure
Overweight Prevalence
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.
